Bank of New York Mellon Corp Tilts From Mega‑Cap AI Winners to Defensives

The most aggressive buy this quarter is not another AI darling but a workhorse: Texas Instruments. Boosting TXN by +33.6% (an estimated +$801.7M) is a clear bet that the less glamorous analog and embedded side of semis is underpriced leverage on the same capex wave that has powered Nvidia and its peers.

Telecom is another quiet winner. Verizon is up +20.8% (about +$330.4M) and AT&T up +12.7% (roughly +$237.7M), suggesting BNYM wants balance-sheet-yield plus optionality on data traffic growth, without paying software-like multiples.

On the macro side, the fund is leaning into a non-US recovery: the iShares Core MSCI EAFE ETF is up +8.4% (around +$267.7M). That sits alongside a more modest yet notable +6.4% increase in Walmart (about +$209.0M), signaling a preference for scale retail and stable traffic over higher-beta consumer names.

Health care is quietly accumulating as well. UnitedHealth is up +10.2% (+$251.9M), reinforcing the pattern: durable cash flows, defensive demand curves, and less dependence on the next rate-cut narrative.

Smaller but telling adds to AMD (+4.2%) and Oracle (+3.0%) show BNYM is not walking away from growth; it is sliding down the quality curve from ultra‑crowded megacaps toward still-profitable, still‑levered names at more palatable entry points.

The funding sources tell you just as much as the buys. The largest trims by dollars are classic profit-taking in hyper-appreciated mega‑cap tech: Apple down -5.9% (about -$1.45B), Microsoft down -5.1% (around -$1.03B), and Nvidia down -2.6% (roughly -$718.6M), all after enormous gains versus BNYM’s average cost.

Alphabet is treated similarly on both share classes: GOOGL is cut -3.8% (about -$454.5M) and GOOG -2.4%. These are risk-budget decisions, not thesis reversals — the names remain top holdings, but the manager is explicitly de‑crowding the most consensus AI platforms.

The most forceful de‑risking comes in financials. Bank of America is slashed -28.9% (roughly -$811.9M), with sizable cuts to JPMorgan (-9.9%, about -$683.1M) and Goldman Sachs (-11.0%). Finance sector weight slips from 5.65% to 5.15%, showing discomfort with broad money‑center and capital markets beta at this stage of the cycle.

Even in semis, there is a subtle quality rotation under the hood. Taiwan Semiconductor is reduced by -20.7% (about -$809.4M), and Micron by -7.6%, while capital flows to Texas Instruments and a small add in AMD. That looks like a shift from highly cyclical or geopolitically sensitive exposures toward steadier, more diversified chip cash flows.

Outside tech and banks, trims in Johnson & Johnson (-10.5%, roughly -$628.8M) and a string of modest cuts across staples, consumer, and industrial blue chips look more like housekeeping — incremental supply of cash rather than a wholesale abandonment of defensives.

At the top-down level, this is a finely tuned rotation, not a regime change. Technology ticks only slightly lower (50.47% to 50.23%), but that small decline hides a deeper reshuffle within the sleeve — away from AI “franchise IP” toward semiconductor infrastructure, diversified software, and connectivity plumbing.

Consumer exposure nudges up (11.77% to 11.96%), powered by higher Walmart weight and steady stakes in Amazon, Costco, and Home Depot. This is a tilt toward scale players that can flex pricing and absorb macro noise, more than a bet on discretionary blow‑out spending.

Unclassified exposures — largely core index and Berkshire — climb from 8.84% to 9.16%, reinforcing the theme of structural diversification alongside high‑conviction single names. Health care is effectively flat at 7.78% but is being internally rebalanced toward UnitedHealth and away from Johnson & Johnson.

Finance and energy both drift lower (finance from 5.65% to 5.15%, energy from 4.30% to 4.17%), signalling less appetite for traditional cyclical and rate‑sensitive beta. Offsetting that, telecommunications rises from 2.65% to 2.96% as BNYM leans harder into Verizon and AT&T, effectively swapping some bank and oil risk for regulated, yield-heavy networks.

Industrials and basic materials weights barely move, but the character of exposure is telling: Tesla and Caterpillar remain prominent industrial bets, while Linde continues as a core chemicals play, all now sitting behind a fatter layer of defensives and global ETFs.

Put together, the book reads like a manager that still believes in the AI-and-cloud super‑theme but no longer trusts the crowd to price tail risk. The trims in Nvidia, Apple, Microsoft, Alphabet, and Taiwan Semiconductor are classic “upgrade your margin of safety” moves — still owning the platforms, but making room for analog, memory, and infrastructure names where expectations are lower.

The simultaneous build-out in telecom, health care, and big-box retail suggests BNYM is preparing for a more volatile policy and macro tape. These are businesses with recurring demand, visible cash flows, and the ability to keep paying and growing dividends even if multiples compress.

The larger stake in iShares Core MSCI EAFE ETF hints at a view that the US exceptionalism trade is rich. A modest re‑weighting to developed ex‑US gives participation in any catch‑up rally while diluting single-country policy and valuation risk.

Finally, the sharp cuts to Bank of America, JPMorgan, and Goldman point to lingering worries about the tails in credit, regulation, or trading-heavy earnings models. Replacing part of that exposure with Verizon, AT&T, and UnitedHealth is a clear statement: the next phase of returns is more likely to come from steady compounding than from another round of beta-driven windfalls.

If the AI cycle extends and global growth muddles through, this configuration should still participate, just with a thicker layer of shock absorbers. If volatility returns in force, the quarter’s rotation shows a manager more interested in surviving the drawdown than squeezing out the last dollar of upside.